Skip to main content
main-content

Obesity, diet, & lifestyle interventions


Browse the latest news, expert commentary, and educational content on obesity and lifestyle interventions.


Highlights

05-06-2021 | Semaglutide | News

FDA approves higher semaglutide dose for obesity

Click through to read more on this announcement

19-05-2021 | Semaglutide | News

Semaglutide boosts weight loss of minimally invasive gastric procedure

Giving semaglutide to people undergoing minimally invasive endoscopic sleeve gastroplasty may bring weight loss closer to that induced by bariatric surgery, shows research.

10-05-2021 | Metabolic surgery | News

Surgery for type 2 diabetes may restore nearly a decade to life expectancy

A meta-analysis shows that bariatric or metabolic surgery markedly increases life expectancy relative to standard obesity care, with the greatest gains seen for people with type 2 diabetes.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

More on obesity & lifestyle interventions

DiRECT: Type 2 diabetes remission through weight management

Primary findings, 2-year outcomes and translating this landmark trial into practice

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits